SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc. (Amendment)

Item 1(a).

Name of Issuer:

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Item 2(a).

Name of Person Filing

Item 2(b).

Address of Principal Business Office or, if None, Residence:

Item 2(c).

Citizenship:

Item 2(d).

Title of Class of Securities:

Item 2(e).

CUSIP Number:

Item 3.

If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),Check Whether the Person Filing is a:

Item 4.

Ownership:

Item 4(a)

Amount Beneficially Owned:

Item 4(b)

Percent of Class:

Item 4(c)

Number of Shares as to which such person has:

	(i)	Sole power to vote or direct the vote:	-0-
	(ii)	Shared power to vote or direct the vote:	-0-
	(iii)	Sole power to dispose or direct the disposition of:	-0-
	(iv)	Shared power to dispose or direct the disposition of:	-0-

Item 5.

Ownership of Five Percent or Less of a Class:

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

Item 8.

Identification and Classification of Members of the Group:

Item 9.

Notice of Dissolution of Group:

Item 10.

Certification:

February 14, 2024
	BRAIDWELL MANAGEMENT LLC AS GENERAL PARTNER OF BRAIDWELL LP
	BY:	/S/ MANISH K. MITAL
		NAME: MANISH K. MITAL
		TITLE: AUTHORIZED SIGNATORY
	BRAIDWELL MANAGEMENT LLC
	BY:	/S/ MANISH K. MITAL
		NAME: MANISH K. MITAL
		TITLE: AUTHORIZED SIGNATORY
	ALEXANDER T. KARNAL
	/s/ ALEXANDER T. KARNAL
	BRIAN J. KREITER
	/s/ BRIAN J. KREITER